Antiangiogenic Effects of the Quinoline-3-Carboxamide Linomide

Cancer Research

Volumn 53, Issue 8, 1993, Pages 1833-1837

  Hartley Asp, Beryl ^f   Hirata, Takahiko ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Department of Urology ^*  (United States)

^c Anesthesiology and Critical Care Medicine   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Laboratories of Biological Chemistry ^*  (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROQUINIMEX;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOSTASIS; DOSE RESPONSE; DRUG SPECIFICITY; ENDOTHELIUM CELL; IMAGE ANALYSIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; TUMOR BLOOD FLOW; TUMOR NECROSIS; UMBILICAL VEIN;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMAN; HYDROXYQUINOLINES; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027212259     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stalhandske, T., Eriksoo, E., and Sandberg, B-M. A novel quinolinecarboxamide with interesting immunomodulatory activity. Int. J. Immunopharmacol., 4: 336-341, 1982.
2. Stalhandke, T., and Kalland, T. Effects of the novel immunomodulator LS-2616 on the delayed-type hypersensitivity reaction to bordotella pertussis in the rat. Immunop-harmacology, 11: 87-92, 1986.
3. Kalland, T., Aim, G., and Stälhandske, T. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator. J. Immunol., 134: 3956-3961, 1985.
4. Larsson, E. L., Joki, A., and Stälhandske, T. Mechanism of action of the new immunomodulator LS26166 on T-cell responses. Int. J. Immunopharmacol., 9: 425-431, 1987.
5. Haming, R., Koo, G. C., and Szalay, J. Regulation of the metastasis of murine ocular melanoma by natural killer cells. Invest. Ophthalmol. Visual Sci., 30: 1909-1915, 1989.
6. Kalland, T. Effects of the immunomodulator LS-2616 on growth and metastasis of the murine B16-F10 melanoma. Cancer Res., 46: 3018-3022, 1986.
7. Haming, R., and Szalay, J. A treatment for metastasis of murine ocular melanoma. Invest. Ophthalmol. Visual Sci., 29: 1505-1510, 1988.
8. Tarkowski, A., Gunnarsson, K., Nilsson, L. A., Lindholm, L., and Stälhandske, T. Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator. Arthritis Rheum., 29: 1405-1409, 1986.
9. Ichikawa, T., Lamb, J. C., Christensson, P. J., Hartley-Asp, B., and Isaacs. J. T. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers. Cancer Res., 52: 3022-3028, 1992.
10. Folkman, J., and Haudenschild, C. Angiogenesis in vitro. Nature (Lond.), 2288: 551-556, 1980.
11. Madri, J. A., Williams, S. K., Wayy, T., and Mezzio, C. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J. Cell. Biol., 97: 153-165, 1983.
12. Sidky, Y. A., and Auerbach, R. Lymphocyte-induced angiogenesis; a quantitative and sensitive assay of the graft-vs-host reaction. J. Exp. Med., 1419: 1084-1100, 1975.
13. Folkman, J. Tumor angiogenesis factor. Cancer Res., 34: 2109-2113, 1974.
14. Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S., and Folkman, J. Tumor dormancy in vivo by presentation of neovascularization. J. Exp. Med., 136: 261-276, 1972.
15. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-203, 1985.
16. Kleinman, H. K., McGarvey, M. L., Hassell. J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin, G. R. Basement membrane complexes with biological activity. Biochemistry, 25: 312-318, 1986.
17. Passaniti, A., Taylor, R. M., Gage, W. R., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and FGF. Lab. Invest., 67: 519-528, 1992.
18. Drabkin, D. L., and Austin, J. H. I. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J. Biol. Chem., 98: 719-733, 1932.
19. DeKlerk, D. P., and Coffey, D. S. Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique: biomorphometrics. Invest. Urol., 16: 240-245, 1978.
20. Isaacs, J. T., Feitz, W. B., and Scheres, J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic ability of prostatic cancer. Prostate, 9: 261-281, 1986.
21. Heymann, M. A., Payne. B. D., Hoffman, J. I. E., and Rudolph, A. M. Blood flow measurements with radionuclide-labeled particles. Prog. Cardiovasc. Dis., 20: 55-79, 1977.
22. Jaffe, E. A. Nachman, R. L., Becker, C. G., and Minick, C. R. Culture of human endothelial cells delivered from umbilical veins: identification by morphological and immunological criteria. J. Clin. Invest., 52: 2745-2756, 1973.
23. Kubota, Y., Kleinman, H. K., Martin, G. R., and Lawley, T. J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol., 107: 1589-1598, 1988.
24. Graf, J., Iwamoto, Y., Sasaki, M., Martin, G. R., Kleinman, H. K., Robey, F. A., and Yamada, Y. Identification of an animo acid sequence in laminin mediating cell attachment, chemotaxis and receptor binding. Cell, 48: 989-996, 1987.
25. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
26. Fridman, R., Kibbey, M. C., Royce, L. S., Zain, M., Sweeney, T. M., Jicha, D. L., Yannelli, J. R., Martin, G. R., and Kleinman, H. K. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J. Natl. Cancer Inst., 83: 769-774, 1991.
27. Young, J. J., Percey, C. L., and Asire, A. J. Surveillance, Epidemiology and End Results: Incidence and Mortality Data. 1973-1977. Washington, D. C.: National Cancer Institute Monograph 57, DHHS Publication No. (NIH) 81-2330, 1981.
28. Seidman, H., Silverberg, E., and Bodden, A. Probabilities of eventually developing and dying of cancer (risk among persons previously undiagnosed with cancer). CA Cancer J. Clin., 28: 336, 1978.
29. Lepor, H., Ross, A., and Walsh, P. C. The influence of hormonal therapy on survival of men with advanced prostatic cancer. J. Urol., 128: 335-340, 1982.
30. Smith, J. A., Jr., and Middleton, R. G. Clinical Management of Prostatic Cancer, pp. 134-161. Chicago. IL: Year Book Medical Publishers, 1987.